Literature DB >> 9786110

A comparison of laser therapy, plastic stents, and expandable metal stents for palliation of malignant dysphagia in patients without a fistula.

A M Gevers1, E Macken, M Hiele, P Rutgeerts.   

Abstract

BACKGROUND: Many options are available for palliation of inoperable malignant stenoses of the esophagus. We report our experience with different modalities of endoscopic therapy.
METHODS: From 1986 to 1996, we treated 125 patients with dysphagia caused by unresectable malignant tumors with endoscopic therapy. Seventy patients were treated with laser therapy, 34 with a plastic endoprosthesis, and 21 with an expandable prosthesis. Therapeutic outcome and complication rates were analyzed for the three groups.
RESULTS: Mean dysphagia score decreased in the same manner in all three groups. Major and minor complications were significantly more common in the plastic endoprosthesis group and in the metallic stent group compared with the laser therapy group. Therapy and patient survival were not significantly different among the three groups.
CONCLUSIONS: Plastic and metal stents carry a high complication rate for a short period of palliation. Endoscopic laser therapy, in contrast, has a low complication rate. Laser therapy should be the first choice for palliation in malignant dysphagia in patients with a short life expectancy. Stents might be used when laser therapy fails, in the presence of fistulas, or in patients with a reasonable life expectancy.

Entities:  

Mesh:

Year:  1998        PMID: 9786110     DOI: 10.1016/s0016-5107(98)70007-0

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  12 in total

1.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

2.  Endoscopic palliative treatment for esophageal and gastric cancer: techniques, complications, and survival in a population-based cohort of 948 patients.

Authors:  A M Thompson; T Rapson; F J Gilbert; K G M Park
Journal:  Surg Endosc       Date:  2004-05-28       Impact factor: 4.584

3.  [Palliative options for esophageal carcinoma].

Authors:  F Hagenmüller
Journal:  Chirurg       Date:  2005-11       Impact factor: 0.955

4.  Self-expanding Polyflex plastic stents in esophageal disease: various indications, complications, and outcomes.

Authors:  C Ott; N Ratiu; E Endlicher; H C Rath; C M Gelbmann; J Schölmerich; F Kullmann
Journal:  Surg Endosc       Date:  2007-06       Impact factor: 4.584

5.  Palliative therapy for esophageal cancer: laser therapy alone is associated with a better functional outcome.

Authors:  Anna Pozza; Francesca R Erroi; Marco Scarpa; Lino Polese; Luigi Rampazzo; Lorenzo Norberto
Journal:  Updates Surg       Date:  2015-01-28

6.  Stents for Esophageal Disease.

Authors:  Frank M. Moses; Roy K.H. Wong
Journal:  Curr Treat Options Gastroenterol       Date:  2002-02

7.  Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study.

Authors:  G M Spencer; S M Thorpe; G M Blackman; J Solano; J S Tobias; L B Lovat; S G Bown
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

8.  History of the Use of Esophageal Stent in Management of Dysphagia and Its Improvement Over the Years.

Authors:  Kulwinder S Dua
Journal:  Dysphagia       Date:  2017-01-18       Impact factor: 3.438

9.  Self-expandable metallic stent placement for patients with inoperable esophageal carcinoma: investigation of the influence of prior radiotherapy and chemotherapy.

Authors:  Yuko Iraha; Sadayuki Murayama; Takafumi Toita; Takashi Utsunomiya; Osamu Nagata; Tamaki Akamine; Kazuhiko Ogawa; Genki Adachi; Noboru Tanigawa
Journal:  Radiat Med       Date:  2006-05

10.  Cost-effectiveness of palliation of unresectable esophageal cancer.

Authors:  Eduardo B da Silveira; Everson L Artifon
Journal:  Dig Dis Sci       Date:  2008-06-04       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.